Aigen Investment Management, LP
Position in AXSM — Axsome Therapeutics, Inc.
CIK 1741224
NEW YORK, NY
Position in AXSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$585,000
+$160,864 QoQ
Shares Held
2,390
-41.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#311
of 503 holders
Holding Since
Dec 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aigen Investment Management, LP holds $12,762,383 across 22 Biotechnology names. AXSM ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,452 | $3,701,631 | |
| 2 | INCY |
Incyte Corp
|
23,563 | $2,671,101 | |
| 3 | INSM |
INSMED Inc
|
16,847 | $1,796,227 | |
| 4 | ASND |
Ascendis Pharma A/S
|
4,073 | $1,086,350 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
This page
|
2,390 | $585,000 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
24,477 | $356,629 | |
| 7 | JANX |
Janux Therapeutics, Inc.
|
22,841 | $350,837 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
5,218 | $314,958 |
All Filings in AXSM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $585,000 | 2,390 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $424,136 | 4,063 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $785,386 | 6,734 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $394,536 | 4,663 | Shares | Sole | 2025-02-06 | |
| 2023-12-31 | $307,694 | 3,866 | Shares | Sole | 2024-02-09 | |
| 2022-12-31 | $234,937 | 3,046 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||